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ABSTRACT
Endonuclease III (Endo III) is a base excision repair
enzyme that recognizes oxidized pyrimidine
bases including thymine glycol. This enzyme is a
glycosylase/lyase and forms a Schiff base-type
intermediate with the substrate after the damaged
base is removed. To investigate the mechanism of
its substrate recognition by X-ray crystallography,
we have synthesized oligonucleotides containing
20-fluorothymidine glycol, expecting that the
electron-withdrawing fluorine atom at the 20 position
would stabilize the covalent intermediate, as
observed for T4 endonuclease V (Endo V) in our pre-
vious study. Oxidation of 50- and 30-protected
20-fluorothymidine with OsO4 produced two isomers
of thymine glycol. Their configurations were deter-
mined by NMR spectroscopy after protection of the
hydroxyl functions. The ratio of (5R,6S) and (5S,6R)
isomers was 3:1, whereas this ratio was 6:1 in the
case of the unmodified sugar. Both of the thymidine
glycol isomers were converted to the corresponding
phosphoramidite building blocks and were incorpor-
ated into oligonucleotides. When the duplexes con-
taining 20-fluorinated 5R-o r5 S-thymidine glycol were
treated with Escherichia coli endo III, no stabilized
covalent intermediate was observed regardless of
the stereochemistry at C5. The 5S isomer was found
to form an enzyme–DNA complex, but the incision
was inhibited probably by the fluorine-induced
stabilization of the glycosidic bond.
INTRODUCTION
Endonuclease III (Endo III) is an enzyme that initiates base
excision repair of oxidatively damaged pyrimidine bases in
DNA (1). Its activity prevents the lethal effects of ionizing
radiation. This important enzyme is highly conserved in
evolution from bacteria to human cells (2–4), and Escherichia
coli Endo III has been studied intensively. The major
substrates for Endo III are 5,6-saturated pyrimidines, such
as 5,6-dihydrothymine, 5,6-dihydro-5-hydroxythymine and
thymine glycol (5,6-dihydro-5,6-dihydroxythymine), and
5-hydroxy-5-methylhydantoin, which is derived by spontan-
eous cyclization of fragmented thymine glycol, formed by
g-irradiation in DNA (5). This enzyme also recognizes
5-hydroxycytosine and 5-hydroxyuracil (6), which have an
unsaturated C5–C6 bond, deoxyribosylurea and an apurinic/
apyrimidinic (AP) site (7,8). Recent studies revealed that
hydantoins derived by further oxidation of 8-oxoguanine
(9), 8-oxoguanine mispaired with guanine (10), and a pyrimi-
dine ring-opened derivative of 1,N
6-ethenoadenine (11) were
removed by Endo III, although this enzyme was less active for
these substrates.
Endo III has two catalytic activities, i.e. DNA glycosylase
and AP lyase. This enzyme removes the damaged base by the
scission of its glycosidic bond ﬁrst and subsequently cleaves
the phosphodiester linkage on the 30 side of the resultant AP
site by a b-elimination reaction. After the ﬁrst step, a Schiff
base-type, covalently-bonded intermediate is formed between
the enzyme and the substrate, as shown in Scheme 1. This
mechanism was originally found in the T4 endonuclease V
(Endo V) reaction (12,13) and was demonstrated for other
glycosylase/AP lyases including Endo III (14). A stable, cova-
lent enzyme–DNA complex can be obtained by reduction of
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doi:10.1093/nar/gkl061the intermediate with sodium borohydride (NaBH4), which
was used to show the presence of such a covalent intermediate
(13,14). This method was applied to crystallization of an
Endo III–DNA complex, and its tertiary structure has been
determined (15). In this structure study, the C–N bond of the
reduced Schiff base was shown clearly, and a candidate for the
amino acid side chain responsible for the b-elimination
reaction was given from the active site structure. However,
the substrate recognition mechanism of this enzyme was not
elucidated because the oxidized base was lost in the reduced
enzyme–DNA complex. Therefore, an alternative crystalliza-
tion method is required to understand the wide substrate spe-
ciﬁcity of Endo III.
Previously, we reported that an oligonucleotide duplex
containing a 20-ﬂuorinated sugar moiety at the cyclobutane
pyrimidine dimer (CPD) site inhibited the T4 Endo V reaction
by stabilizing the covalent enzyme–DNA complex without
the NaBH4 reduction (16). We reasoned that the
electron-withdrawing ﬂuorine atom at the C20 position stabil-
ized the cyclic hemiacetal form of the sugar moiety, which is
inactive in the b-elimination reaction, after the N-terminal
a-amino group of the enzyme formed a covalent bond with
the 10 carbon of the substrate. Since a crystal structure of the
T4 Endo V–DNA complex was successfully determined using
a mutant enzyme (17), this system was not applied to crys-
tallization. Here we describe the synthesis of oligonucleotides
containing 20-ﬂuorinated thymidine glycol, which are possible
inhibitors of the Endo III reaction and may be used for
crystallization of the enzyme–DNA complex. The enzyme
reaction with the modiﬁed oligonucleotide duplexes is also
reported.
MATERIALS AND METHODS
For the chemical synthesis, the general methods are basically
the same as those reported previously (18,19). The starting
material, 20-ﬂuorothymidine [1-(2-deoxy-2-ﬂuoro-b-D-
ribofuranosyl)thymine], was purchased from R.I. Chemical
(Orange, CA).
1H-NMR spectra were measured on a JEOL
AL-400 or Varian INOVA 600 spectrometer, and
31P-NMR
spectra were measured on a JEOL GSX270 spectrometer using
trimethyl phosphate as an internal standard. Mass spectra were
obtained on a Micromass LCT spectrometer. Matrix-assisted
laser desorption/ionization time-of-ﬂight (MALDI-TOF) mass
spectra of oligonucleotides were measured in the negative
ion mode on an Applied Biosystems Voyager DE PRO
spectrometer, using 3-hydroxypicolinic acid as a matrix.
50-O-(4,40-Dimethoxytrityl)-30-O-benzoyl-20-
fluorothymidine (1)
To a solution of 50-O-(4,40-dimethoxytrityl)-20-
ﬂuorothymidine (4.76 g, 8.46 mmol) in pyridine (32 ml),
benzoyl chloride (1.11 ml, 9.60 mmol) was added, and the
mixture was stirred in an ice bath for 3 h. Chloroform (80 ml)
was added, and the mixture was washed with saturated
Scheme 1. The proposed mechanism for the T4 Endo V and Endo III reactions.
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organic layer was dried with Na2SO4, and after evaporation
and coevaporation with toluene, the residue was chromato-
graphed on silica gel (80 g). The product was eluted with
chloroform and was obtained as foam after evaporation.
Yield: 5.13 g (7.69 mmol, 91%). TLC (CHCl3/MeOH, 10/1,
v/v):Rf:0.81.
1HNMR(400MHz,CDCl3,30  C,TMS):d 8.10
(s, 1H; -NH-), 8.03 (dd, J ¼ 8.4, 1.3 Hz, 2H; bz), 7.62 (tt, J ¼
7.4, 1.8 Hz, 1H; bz), 7.53 (d, J ¼ 1.3 Hz, 1H; H6), 7.47 (t, J ¼
8.1 Hz, 2H; bz), 7.39 (dd, J ¼ 6.9, 1.6 Hz, 2H; DMT),
7.30–7.15 (m, 7H; DMT), 6.79 (t, J ¼ 8.1 Hz, 4H; DMT),
6.20 (dd, J ¼ 16.2, 3.1 Hz, 1H; H10), 5.67–5.60 (m, 1H; H30),
5.50 (dd, J ¼ 4.8, 3.1 Hz, 0.5H; H20), 5.37 (dd, J ¼ 4.7, 3.1 Hz,
0.5H; H20), 4.48–4.44 (m, 1H; H40), 3.75 (s, 3H; -OCH3), 3.74
(s, 3H; -OCH3), 3.63 (dd, J ¼ 11.2, 2.4 Hz, 1H; H50), 3.49 (dd,
J ¼ 11.2, 2.8 Hz, 1H; H50), 1.51 (s, 3H; -CH3). HRMS (ESI):
m/z: 689.2273 ([M+Na]
+,C 38H35O8N2FNa: 689.2270).
50-O-(4,40-Dimethoxytrityl)-30-O-benzoyl-5,6-dihydro-
5,6-dihydroxy-20-fluorothymidine (2a and 2b)
50-O-(4,40-Dimethoxytrityl)-30-O-benzoyl-20-ﬂuorothymidine
(1) (2.62 g, 3.93 mmol) was mixed with osmium tetroxide
(1.0 g, 3.93 mmol) in pyridine (10 ml), and this mixture
was stirred at room temperature for 2 h. Sodium hydrogen
sulﬁte (1.8 g) dissolved in water (30 ml) and pyridine
(20 ml) was added, and the mixture was stirred further for
30 min. The product was extracted with chloroform (100 ml),
and the organic layer was dried with Na2SO4. After evapora-
tion, the pyridine was removed by coevaporation with toluene,
and the residue was chromatographed on silica gel (70 g). Two
isomers were separated by elution with diethyl ether, and their
conﬁgurations were determined after the protection of the
hydroxyl functions, as described in the text.
5R,6S-Isomer (2a). Yield: 1.24 g (1.77 mmol, 45%). TLC
(diethyl ether): Rf: 0.31.
1H-NMR (400 MHz, CDCl3,3 0  C,
TMS): d 8.01 (dd, J ¼ 8.5, 1.4 Hz, 2H; bz), 7.60 (tt, J ¼ 7.6,
1.2 Hz, 1H; bz), 7.52 (s, 1H; -NH-), 7.45 (t, J ¼ 8.0 Hz, 2H;
bz), 7.40 (dd, J ¼ 8.6, 1.5 Hz, 2H; DMT), 7.31–7.15 (m, 7H;
DMT), 6.79–6.74 (m, 4H; DMT), 6.15 (dd, J ¼ 18.8, 2.4 Hz,
1H; H10), 5.67–5.59 (m, 1H; H30), 5.60 (dd, J ¼ 4.9, 2.2 Hz,
0.5H; H20), 5.46 (dd, J ¼ 4.9, 2.7 Hz, 0.5H; H20), 5.31 (s, 1H;
H6), 4.36–4.32 (m, 1H; H40), 3.72 (s, 3H; -OCH3), 3.71 (s, 3H;
-OCH3), 3.59 (dd, J ¼ 11.2, 2.4 Hz, 1H; H50), 3.56 (s, 1H;
6-OH), 3.43 (dd, J ¼ 11.0, 3.2 Hz, 1H; H50), 3.26 (s, 1H;
5-OH), 1.43 (s, 3H; -CH3). HRMS (ESI): m/z: 723.2349
([M+Na]
+,C 38H37O10N2FNa: 723.2324).
5S,6R-Isomer (2b). Yield: 438 mg (625 mmol, 16%). TLC
(diethyl ether): Rf: 0.15.
1H-NMR (400 MHz, CDCl3,3 0  C,
TMS):d 8.04(dd,J¼8.3,1.2Hz,2H;bz),7.62(tt,J¼7.6,1.4
Hz, 1H; bz),7.47 (t, J ¼8Hz, 2H; bz), 7.44 (s,1H; -NH-),7.37
(dd, J ¼ 7.1, 1.5 Hz, 2H; DMT), 7.27 (dd, J ¼ 9.0, 1.7 Hz, 4H;
DMT), 7.24–7.16 (m, 3H; DMT), 6.81–6.75 (m, 4H; DMT),
6.23 (dd, J ¼ 19.5, 3.4 Hz, 1H; H10), 5.57–5.49 (m, 1H; H30),
5.37 (dd, J ¼ 5.4, 3.4 Hz, 0.5H; H20), 5.24 (dd, J ¼ 5.2, 3.4 Hz,
0.5H; H20), 4.94 (d, J ¼ 1.9 Hz, 1H; H6), 4.37–4.32 (m, 1H;
H40), 3.72 (s, 6H; -OCH3), 3.67 (d, J ¼ 2.0 Hz, 1H; 6-OH),
3.53 (d, J ¼ 2.7 Hz, 2H; H50), 3.21 (s, 1H; 5-OH), 1.52 (s, 3H;
-CH3). HRMS (ESI): m/z: 723.2351 ([M+Na]
+,C 38H37O10N2
FNa: 723.2324).
50-O-(4,40-Dimethoxytrityl)-30-O-benzoyl-(5R,6S)-5,
6-dihydro-5,6-di[(tert-butyl)dimethylsilyloxy]-20-
fluorothymidine (3a)
To a solution of 50-O-(4,40-dimethoxytrityl)-30-O-benzoyl-
(5R,6S)-5,6-dihydro-5,6-dihydroxy-20-ﬂuorothymidine (2a)
(443 mg, 633 mmol) in N,N-dimethylformamide (7 ml),
imidazole (431 mg, 6.33 mmol) and tert-butyldimethyl-
chlorosilane (500mg,3.31mmol)were added, andthe mixture
was stirred at 37 C for 24 h. This mixture was diluted with
chloroform (50 ml) and was washed with 0.5 M sodium phos-
phate (pH 5.0). The organic layer was dried with Na2SO4, and
after evaporation and coevaporation with toluene, the residue
was chromatographed on silica gel (30 g) with a step gradient
of ethyl acetate in hexane. The product was eluted with 15%
ethyl acetate in hexane and was obtained as foam after evap-
oration. Yield: 528 mg (568 mmol, 90%). TLC (hexane/ethyl
acetate, 3/2, v/v): Rf: 0.59.
1H NMR (400 MHz, CDCl3,3 0  C,
TMS):d 8.00(dd,J¼8.0,1.0Hz,2H;bz),7.58(tt,J¼7.4,1.2
Hz, 1H; bz), 7.45 (d, J ¼ 8.0 Hz, 2H; bz), 7.45–7.41 (m, 2H;
DMT), 7.31 (dt, J ¼ 8.8, 2.1 Hz, 4H; DMT), 7.22–7.13 (m, 3H;
DMT), 7.10 (s, 1H; -NH-), 6.74 (d, J ¼ 8.3 Hz, 4H; DMT),
5.61 (dd, J ¼ 5.6, 2.6 Hz, 0.5H; H20), 5.48 (dd, J ¼ 5.7, 2.6 Hz,
0.5H; H20), 5.45–5.35 (m, 1H; H30), 5.18 (dd, J ¼ 24.0, 2.6 Hz,
1H; H10), 4.67 (s, 1H; H6), 4.31–4.25 (m, 1H; H40), 3.73
(s, 6H; -OCH3), 3.43 (d, J ¼ 4.8 Hz, 2H; H50), 1.47 (s, 3H;
-CH3), 0.87 (s, 9H; TBDMS), 0.84 (s, 9H; TBDMS), 0.27
(s, 3H; TBDMS), 0.23 (s, 3H; TBDMS), 0.22 (s, 3H;
TBDMS), 0.16 (s, 3H; TBDMS). HRMS (ESI): m/z:
951.4040 ([M+Na]
+,C 50H65O10N2FSi2Na: 951.4053).
50-O-(4,40-Dimethoxytrityl)-30-O-benzoyl-(5S,6R)-5,
6-dihydro-5,6-di[(tert-butyl)dimethylsilyloxy]-20-
fluorothymidine (3b)
To a solution of 50-O-(4,40-dimethoxytrityl)-30-O-benzoyl-
(5S,6R)-5,6-dihydro-5,6-dihydroxy-20-ﬂuorothymidine (2b)
(338 mg, 482 mmol) in N,N-dimethylformamide (6 ml),
imidazole (330 mg, 4.82 mmol) and tert-butyldimethyl-
chlorosilane (363mg,2.41mmol)were added, andthe mixture
was stirred at 37 C for 30 h. This mixture was diluted with
chloroform (50 ml) and was washed with 0.5 M sodium phos-
phate (pH 5.0). The organic layer was dried with Na2SO4, and
after evaporation and coevaporation with toluene, the residue
was chromatographed on silica gel (30 g) with a step gradient
of ethyl acetate in hexane. The product was eluted with 15%
ethyl acetate in hexane and was obtained as foam after evap-
oration. Yield: 408 mg (439 mmol, 91%). TLC (hexane/ethyl
acetate, 3/2, v/v): Rf: 0.62.
1H NMR (400 MHz, CDCl3,3 0  C,
TMS): d 8.00 (dd, J ¼ 7.2, 1.2 Hz, 2H; bz), 7.58 (tt, J ¼ 7.4,
1.2 Hz, 1H; bz), 7.44 (d, J ¼ 7.9 Hz, 2H; bz), 7.42–7.38 (m,
2H; DMT), 7.27 (d, J ¼ 8.9 Hz, 4H; DMT), 7.21–7.14 (m, 3H;
DMT), 7.07 (s, 1H; -NH-), 6.72 (dd, J ¼ 9.0, 2.6 Hz,
4H; DMT), 5.83 (d, J ¼ 4.8 Hz, 0.5H; H20), 5.69 (d, J ¼
4.9 Hz, 0.5H; H20), 5.62–5.55 (m, 1H; H30), 5.20 (d, J ¼
24.4 Hz, 1H; H10), 4.72 (s, 1H; H6), 4.36–4.30 (m, 1H;
H40), 3.72 (s, 6H; -OCH3), 3.39 (d, J ¼ 4.4 Hz, 2H; H50),
1.53 (s, 3H; -CH3), 0.88 (s, 9H; TBDMS), 0.85 (s, 9H;
TBDMS), 0.26 (s, 3H; TBDMS), 0.21 (s, 3H; TBDMS),
0.12 (s, 3H; TBDMS), 0.10 (s, 3H; TBDMS). HRMS (ESI):
m/z: 951.4039 ([M+Na]
+,C 50H65O10N2FSi2Na: 951.4053).
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6-dihydro-5,6-di[(tert-butyl)dimethylsilyloxy]-20-
fluorothymidine (4a)
50-O-(4,40-Dimethoxytrityl)-30-O-benzoyl-(5R,6S)-5,6-dihydro-
5,6-di[(tert-butyl)dimethylsilyloxy]-20-ﬂuorothymidine (3a)
(465 mg, 500 mmol) was dissolved in a 50 mM solution of
potassium carbonate in anhydrous methanol (14 ml). This
mixture was stirred at room temperature for 3 h. After the
solution was cooled in an ice bath, 0.5 M sodium phosphate
(pH 5.0, 14 ml) was added, and the product was extracted
with chloroform (50 ml). The organic layer was dried with
Na2SO4, and after evaporation, the residue was chrom-
atographed on silica gel (30 g) with a step gradient of ethyl
acetate in hexane. The product was eluted with 20% ethyl
acetate in hexane and was obtained as foam after evapor-
ation. Yield: 394 mg (478 mmol, 96%). TLC (hexane/ethyl
acetate, 3/2, v/v): Rf: 0.43.
1H NMR (400 MHz, CDCl3,3 0  C,
TMS): d 7.44 (d, J ¼ 7.7 Hz, 2H; DMT), 7.32 (dt, J ¼ 8.9,
2.1 Hz, 4H; DMT), 7.27–7.16 (m, 3H; DMT), 7.12 (s, 1H;
-NH-), 6.80 (d, J ¼ 8.9 Hz, 4H; DMT), 5.28 (dd, J ¼ 5.5,
2.7 Hz, 0.5H; H20), 5.14 (dd, J ¼ 5.5, 2.6 Hz, 0.5H; H20), 5.11
(dd, J ¼ 24.3, 2.8 Hz, 1H; H10), 4.64 (s, 1H; H6), 4.40–4.30
(m, 1H; H30), 3.89–3.83 (m, 1H; H40), 3.78 (s, 6H; -OCH3),
3.41–3.31 (m, 2H; H50), 2.02 (dd, J ¼ 7.9, 3.8 Hz, 1H;
30-OH), 1.46 (s, 3H; -CH3), 0.87 (s, 9H; TBDMS), 0.83
(s, 9H; TBDMS), 0.26 (s, 3H; TBDMS), 0.22 (s, 3H;
TBDMS), 0.19 (s, 3H; TBDMS), 0.15 (s, 3H; TBDMS).
HRMS (ESI): m/z: 847.3785 ([M+Na]
+,C 43H61O9N2FSi2Na:
847.3791).
50-O-(4,40-Dimethoxytrityl)-(5S,6R)-5,
6-dihydro-5,6-di[(tert-butyl)dimethylsilyloxy]-20-
fluorothymidine (4b)
50-O-(4,40-Dimethoxytrityl)-30-O-benzoyl-(5S,6R)-5,6-dihydro-
5,6-di[(tert-butyl)dimethylsilyloxy]-20-ﬂuorothymidine (3b)
(372 mg, 400 mmol) was dissolved in a 50 mM solution of
potassium carbonate in anhydrous methanol (10 ml). This
mixture was stirred at room temperature for 2 h. After the
solution was cooled in an ice bath, 0.5 M sodium phosphate
(pH 5.0, 10 ml) was added, and the product was extracted
with chloroform (50 ml). The organic layer was dried with
Na2SO4, and after evaporation, the residue was chrom-
atographed on silica gel (25 g) with a step gradient of ethyl
acetate in hexane. The product was eluted with 20% ethyl
acetate in hexane and was obtained as foam after evapor-
ation. Yield: 307 mg (372 mmol, 85%). TLC (hexane/ethyl
acetate, 3/2, v/v): Rf: 0.43.
1H NMR (400 MHz, CDCl3,3 0  C,
TMS): d 7.42 (dd, J ¼ 7.1, 1.6 Hz, 2H; DMT), 7.31
(d, J ¼ 8.9 Hz, 4H; DMT), 7.25–7.16 (m, 3H; DMT), 7.10
(d, J ¼ 10 Hz, 1H; -NH-), 6.79 (d, J ¼ 8.0 Hz, 4H; DMT), 5.51
(d, J ¼ 4.8 Hz, 0.5H; H20), 5.38 (d, J ¼ 4.9 Hz, 0.5H; H20),
5.09 (d, J ¼ 25.9 Hz, 1H; H10), 4.70 (s, 1H; H6), 4.57–4.46
(m, 1H; H30), 3.89–3.84 (m, 1H; H40), 3.78 (s, 6H; -OCH3),
3.38–3.30 (m, 2H; H50), 2.04–1.98 (m, 1H; 30-OH), 1.53
(s, 3H; -CH3), 0.88 (s, 9H; TBDMS), 0.86 (s, 9H;
TBDMS), 0.25 (s, 3H; TBDMS), 0.20 (s, 3H; TBDMS),
0.14 (s, 3H; TBDMS), 0.12 (s, 3H; TBDMS). HRMS:
(ESI) m/z: 847.3778 ([M+Na]
+,C 43H61O9N2FSi2Na:
847.3791).
50-O-(4,40-Dimethoxytrityl)-5,6-dihydro-5,
6-di[(tert-butyl)dimethylsilyloxy]-20-fluorothymidine
30-[(2-cyanoethyl)-N,N-diisopropyl]phosphoramidite
(5a and 5b)
To a solution of 50-O-(4,40-dimethoxytrityl)-5,6-dihydro-5,6-
di[(tert-butyl)dimethylsilyloxy]-20-ﬂuorothymidine (4a or 4b)
(166 mg, 201 mmol) in tetrahydrofuran (4 ml), N,N-diiso-
propylethylamine (208 ml, 1.20 mmol) and (2-cyanoethyl)-N,
N-diisopropylchlorophosphoramidite (134 ml, 600 mmol) were
added. This mixture was stirred for 1 h, diluted with ethyl
acetate, and washed with 2% NaHCO3 and water. The organic
layer was dried with Na2SO4, and after evaporation, the
residue was chromatographed on silica gel (5 g) with a step
gradient of ethyl acetate in hexane containing 0.1% pyridine.
The product was eluted with 20% ethyl acetate, and after
evaporation, the pyridine was removed by coevaporation
with acetonitrile. (5a) Yield: 145 mg (141 mmol, 70%).
31P-NMR (109.25 MHz, CDCl3,3 0  C, trimethyl phosphate):
d 148.3, 147.8 p.p.m. HRMS (ESI): m/z: 1025.5058 ([M+H]
+,
C52H79FN4O10PSi2: 1025.5051). (5b) Yield: 169 mg
(165 mmol, 82%).
31P-NMR (109.25 MHz, CDCl3,3 0  C, tri-
methyl phosphate): d 148.7, 147.7 p.p.m. HRMS (ESI): m/z:
1025.5045 ([M+H]
+,C 52H79FN4O10PSi2: 1025.5051).
Oligonucleotide synthesis
The phosphoramidite building blocks of 20-ﬂuorothymidine
glycols (5a and 5b) were dissolved in anhydrous acetonitrile
at a concentration of 0.1 M and were installed on an Applied
Biosystems Model 394 or 3400 DNA synthesizer. Nucleoside
phosphoramidites for ultramild DNA synthesis (Glen
Research), as well as the base-unprotected thymidine phos-
phoramidite, were also dissolved in acetonitrile to make 0.1 M
solutions and were installed on the synthesizer. Oligonuc-
leotides were synthesized on a 0.2 or 1.0 mmol scale, and
the reaction time for the coupling of 5a and 5b was pro-
longed to 5 min. After chain assembly and removal of the
4,40-dimethoxytrityl (DMT) group at the 50 end on the syn-
thesizer, the solid supports containing the oligonucleotides
were treated with 28% aqueous ammonia (2 ml) at room
temperature for 2 h. The resulting ammoniac solutions were
concentrated to dryness on a rotary evaporator equipped with a
vacuum pump. The residues were dissolved in triethylamine
trihydroﬂuoride (500 ml) (Aldrich), and the mixtures were kept
at 40 C overnight. After desalting on a NAP-10 column
(Amersham Biosciences), the oligonucleotides were analyzed
and puriﬁed by high-performance liquid chromatography
(HPLC). For analysis, a mBondasphere C18 5mm 300 s
column (3.9 · 150 mm) (Waters) was used with a linear gra-
dient of acetonitrile [6–11% (13mers) or 7–13% (40-mers) for
20 min] in 0.1 M triethylammonium acetate (pH 7.0). For
puriﬁcation, a mBondasphere C18 15 mm 300 s column
(7.8 · 300 mm) (Waters) was used, and the acetonitrile
gradient was 8–13% for 30 min.
32P-labeling of a CPD-containing oligonucleotide
A 34mer, d(GGCTTGTCACTATCGCGTF[]TGCGCTA-
CAGTAAGTG), where TF[]T represents the cis–syn CPD
with a ﬂuorine atom attached at the 20 upper position of the
50 component, was prepared as described previously (16). For
50-labeling, this oligonucleotide (60 pmol) was incubated with
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32P]ATP and T4 polynucleotide kinase (10 U) (Takara Bio)
in a buffer (50 ml) containing 50 mM Tris–HCl (pH 9.5),
10 mM MgCl2, 5 mM DTT and 5% glycerol at 37 C, and
after 30 min, the mixture was heated to 75 C for 15 min. For
30-labeling, the 34mer (60 pmol) was incubated with
[a-
32P]ATP and terminal deoxynucleotidyl transferase
(40 U) (Amersham Biosciences) in a buffer (50 ml) containing
10 mM Tris-acetate (pH 7.5), 10 mM magnesium acetate and
50 mM potassium acetate at 37 C, and after 15 min, 0.5 M
EDTA (5 ml) was added. In both cases, the labeled oligonuc-
leotide was puriﬁed using a ProbeQuant G-50 Micro Column
(Amersham Biosciences).
Formation of the T4 Endo V–DNA complex
The
32P-labeled 34mer was hybridized with a 1.25-fold excess
of the complementary strand by heating the solution to 80 C
for 5 min and cooling it to 4 C. The binding reaction (20 ml)
contained the 50-o r3 0-
32P-labeled duplex (1 pmol) and T4
Endo V (10 pmol) in 32 mM Tris–HCl (pH 7.5), 9.6 mM
EDTA and 100 mM NaCl. The mixtures were incubated at
30 C for 30 min and were subjected to 15% SDS–PAGE,
followed by detection of the bands by autoradiography.
Trapping of the covalent intermediate in the
Endo III reaction
The
32P-labeled 13 bp duplexes (10 nM) containing the 5R or
5S isomer of thymidine glycol or 20-ﬂuorothymidine glycol,
32P-d(ACGCGATgACGCCA)·d(TGGCGTATCGCGT), in
which Tg represents thymine glycol, were incubated with
E.coli Endo III (10 or 100 nM) at 25 C for 30 or 60 min in
a buffer (10 ml) containing10 mM Tris–HCl (pH 7.5),100 mM
NaCl, 1 mM EDTA, 0.1 mg/ml BSA and 0 or 50 mM NaBH4.
The mixtures were analyzed by 10% SDS–PAGE.
Binding of Endo III
The
32P-labeled 13 bp duplexes (10 nM) containing the 5R or
5S isomer of 20-ﬂuorothymidine glycol were incubated with
E.coliEndoIII(0–100 nM)onicefor30mininabuffer(10ml)
containing 10 mM Tris–HCl (pH 7.5), 100 mM NaCl, 1 mM
EDTA and 0.1 mg/ml BSA. The mixtures were analyzed by
6% non-denaturing PAGE.
Analysis of the Endo III reaction
The
32P-labeled 13 bp duplexes (10 nM) containing the 5R or
5S isomer of thymidine glycol or 20-ﬂuorothymidine glycol
were incubated with E.coli Endo III (10 nM) at 25 C for 10
or 30 min in a buffer (10 ml) containing 10 mM Tris–HCl
(pH 7.5), 100 mM NaCl, 1 mM EDTA and 0.1 mg/ml BSA.
The enzyme reactions were performed at 25 C because of the
low melting temperature (ca. 35 C) of the thymine glycol-
containing duplexes. The mixtures were analyzed by 16%
denaturing PAGE. To analyze the inhibitory effect of
20-ﬂuorothymidine glycol on the Endo III reaction, the
32P-labeled 13 bp substrate duplexes without ﬂuorine
(10 nM) were incubated with Escherichia coli Endo III
(10 and 2 nM in the cases of 5R- and 5S-thymine glycols,
respectively) at 25 C for 20 min, in the presence of the 13 bp
duplex containing the 5R or 5S isomer of 20-ﬂurothymidine
glycol (0–160 nM) as a competitor. The products were ana-
lyzed by denaturing PAGE, as described above. For the kinetic
analysis, similar reactions were performed using the substrate
duplexes (2.5–150 nM) and the competitor (80 nM). The para-
meters were obtained by the Lineweaver–Burk plots.
RESULTS
Complex formation of T4 Endo V
In our previous study (16), an oligonucleotide duplex contain-
ing a ﬂuorine atom at the 20 position of the 50 component of the
CPD was prepared, and its reaction with T4 Endo V, which is a
DNA glycosylase/AP lyase speciﬁc for the CPD, was ana-
lyzed. Because the enzyme reaction with this substrate analog
was inhibited, two sets of experiments were carried out to
verify the formation of an enzyme–DNA complex with a sta-
bilized covalent bond. In one experiment, the covalent com-
plex was detected by SDS–PAGE and was compared with that
formed between the enzyme and a normal substrate under the
NaBH4-reducing conditions. In the other experiment, the reac-
tion with the normal substrate was inhibited by pre-treatment
of the enzyme with an equimolar amount of the ﬂuorinated
analog. Although these experiments clearly showed that the
20-ﬂuorine atom stabilized the covalently-bonded intermediate
without the NaBH4 treatment, we recently noticed an import-
ant point to be conﬁrmed. For the SDS–PAGE analysis, the
50 end of the CPD-containing strand was labeled with
[g-
32P]ATP and T4 polynucleotide kinase. This means that
only the 50 side of the CPD site was proven to be intact. If
there is an equilibrium between the cyclic hemiacetal and
acyclic imino forms of the sugar moiety, the ﬂuorine atom
might have inhibited only the hydrolysis of the C–N bond at
the product release step, and the chain might have been
cleaved because the hydrogen at the 20 ‘upper’ position that
should be abstracted in the b-elimination reaction (20) was
present in this substrate analog. Therefore, we analyzed the T4
Endo V reaction using the 30-
32P-labeled substrate analog to
conﬁrm that the entire chain was intact in the complex, prior to
the Endo III studies.
A 34mer duplex, d(GGCTTGTCACTATCGCGTF[]TGC-
GCTACAGTAAGTG)·d(CACTTACTGTAGCGCAACGC-
GATAGTGACAAGCC), where TF[]T represents the cis–syn
CPD with a ﬂuorine atom attached at the 20 ‘lower’ position,
was used. The 50 and 30 ends of the CPD-containing strand
were labeled using T4 polynucleotide kinase and terminal
deoxynucleotidyl transferase, respectively, and these oligo-
nucleotides were hybridized to the complementary strand.
Formation of the stabilized intermediate in the T4 Endo V
reaction was analyzed by SDS–PAGE. As shown in Figure 1,
the result of the experiment using the duplex labeled at the
30 end (lane 4) was identical to that using the 50-labeled one
(lane 2).
Synthesis of the building blocks for the incorporation of
20-fluorothymidine glycol (TgF)
The lack of chain cleavage for the T4 Endo V reaction with the
20-ﬂuorinated substrate analog indicated the practicality of
these types of mechanism-based inhibitors for crystallo-
graphic studies. For application to Endo III, we planned to
synthesize oligonucleotides containing 20-ﬂuorothymidine
glycol (TgF, 1-(2-deoxy-2-ﬂuoro-b-D-ribofuranosyl)-5,
1544 Nucleic Acids Research, 2006, Vol. 34, No. 56-dihydro-5,6-dihydroxythymine). For this purpose, we
prepared the phosphoramidite building blocks, as shown in
Scheme 2, separately using the two stereoisomers of thymine
glycol.
Our procedure was basically the same as that developed for
the building block of thymidine glycol without ﬂuorine
(18,19). Oxidation of 20-ﬂuorothymidine (1-(2-deoxy-2-
ﬂuoro-b-D-ribofuranosyl)thymine) gave two products, which
were supposed to be the two isomers of cis-thymine glycol.
The ratio of the isolation yields of these products was 3:1. In
our previous study, the conﬁguration of each isomer was
determined from the NOESY spectra in
1H-NMR spectro-
scopy, on the basis of the observation that the base moiety
was in the anti conformation about the glycosidic bond (18).
However, NOESY crosspeaks supporting this conformation
were not obtained for our current products (2a and 2b in
Scheme 2), probably because the sugar pucker was changed
from C20-endo to C30-endo by the ﬂuorine substitution (21–
24). Therefore, the two hydroxyl functions of the base moiety
were protected with the tert-butyldimethylsilyl (TBDMS)
Figure 1. Formation of the covalent complex between T4 Endo V and a
CPD-containing oligonucleotide duplex fluorinated at the 20 position. The 50
and30 endsoftheCPD-containingstrandwere
32P-labeled.Afterhybridization
withthecomplementarystrand,theduplexeswereincubatedwithT4EndoVat
30 C for 30 min, and the mixtures were subjected to 15% SDS–PAGE.
Scheme 2. Synthesis of phosphoramidite building blocks of the two isomers of TgF. (i) OsO4, pyridine, room temperature, 2 h; (ii) TBDMS-Cl (five equivalents),
imidazole,DMF,37 C,24h;(iii)K2CO3,MeOH,roomtemperature,2h;(iv)[(CH3)2CH]2NP(Cl)OCH2CH2CN,[(CH3)2CH]2NC2H5,THF,roomtemperature,1h.
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(3a and 3b), which would ﬁx the glycosyl torsion angle in the
syn conformation, were used to determine the stereochemistry.
As shown in Figure 2, a strong nuclear Overhauser effect
(NOE) was detected between H6 and H10 for both isomers,
which showed that the base moiety was in the syn conforma-
tion. For the major isomer obtained by the OsO4 oxidation, a
relatively strong NOE was observed between H6 and H20,
whereas the minor one showed only a slight effect. From
this result, the thymine glycols in the major and minor
products were assigned as (5R,6S)( 2a) and (5S,6R)( 2b),
respectively.
After the benzoyl (Bz) group at the 30 position was removed
with potassium carbonate, the 30 hydroxyl function of each
isomer was phosphitylated to obtain the phosphoramidite
building blocks (5a and 5b) for oligonucleotide synthesis
(19). Because the phosphitylation reaction was slow, an excess
amount (three equivalents) of the chlorophosphoramidite
reagent was used, and the reaction time was prolonged to 1 h.
Synthesis of oligonucleotides containing TgF
Assembly of oligonucleotides on a DNA synthesizer, using
compounds 5a and 5b, was carried out in the same way as
reported previously for thymidine glycol without ﬂuorine
(18,19). The coupling yield in each cycle was monitored by
a conductivity sensor on the synthesizer. Although the values
obtained by this method contained relatively large errors, the
coupling yields of 5a and 5b were between 94 and 108%,
which were similar to those of the 20-deoxynucleoside
30-phosphoramidites with the normal bases. Since thymine
glycol is labile under alkaline conditions used for oligonuc-
leotide deprotection, commercially available nucleoside
30-phosphoramidites bearing base-labile protecting groups,
i.e. phenoxyacetyl, (4-isopropylphenoxy)acetyl and acetyl
groups for adenine, guanine and cytosine, respectively,
were used. A 13mer, d(ACGCGATgFACGCCA) and a
40mer, d(GCATGCCTGCACGGTgFCATGGCCAGATCCC-
CGGGTACCGAG), were synthesized, separately incorporat-
ing the thymine glycol isomers.
After the removal of the last DMT group on the synthesizer,
the oligonucleotides were cleaved from the solid support with
ammonium hydroxide at room temperature for 2 h, and the
amino groups on the base moieties and the internucleotide
phosphates were deprotected simultaneously by this treatment.
The procedure for the subsequent removal of the TBDMS
group was changed from the original method. We previously
used tetrabutylammonium ﬂuoride (TBAF) at this step and
found the formation of 5-hydroxy-5-methylhydantoin as a
byproduct (19). Glen Research reported that removal of the
TBDMS group with triethylamine trihydroﬂuoride, which was
originally used for oligoribonucleotide synthesis (25), did not
cause this side reaction [The Glen Report, Vol. 16, No. 1, page
4 (2003)]. We adopted this method, and the results are shown
in Figure 3. Because the C6 position of deprotected thymine
glycol is epimerized in solution (26), we describe the stereo-
chemistry only at the C5 position for the obtained oligonuc-
leotides. HPLC analysis on a reversed-phase column gave a
single main peak in all cases. The retention times of the oli-
gonucleotides containing 5R-thymine glycol were longer than
that of each 5S counterpart. This result is identical with that
obtained for the sugar-unmodiﬁed oligonucleotides in our pre-
viousstudy(19).Theproductswere puriﬁedbyreversed-phase
HPLC, and the molecular weights of the 13mers were con-
ﬁrmed by MALDI-TOF mass spectrometry, as shown in
Figure 4.
Analysis of the Endo III reaction
Using the 13mer, d(ACGCGATgFACGCCA), the Endo III
reaction with the ﬂuorine-containing substrate analogs was
analyzed. After
32P-labeling, the 13mers containing the 5R
and 5S isomers of TgF were separately hybridized to the com-
plementary strand, d(TGGCGTATCGCGT). For comparison,
32P-labeled, thymine glycol-containing duplexes without ﬂu-
orine were prepared in the same way. We ﬁrst tried to detect
the stable covalent intermediate in the reaction between E.coli
Endo III and the ﬂuorine-containing duplexes. Contrary to our
expectation, however, such an intermediate was not observed
in the analysis by SDS–PAGE, as shown in Figure 5, whereas
the Schiff base-type intermediate was trapped with sodium
borohydride in the reaction with the non-ﬂuorinated sub-
strates. Then, we analyzed the binding and the incision reac-
tion of Endo III. As shown in Figure 6, it was found by
electrophoretic mobility shift assays (EMSAs) that E.coli
Endo III formed a complex with the 13 bp duplex containing
20-ﬂuoro-5S-thymidine glycol (5S-TgF). Binding was not
detected for 5R-TgF. Cleavage of the thymine glycol-
containing strand was not detected for either of the ﬂuorinated
substrateanalogs (Figure7).Fromthese results,itisconcluded
that the duplex containing 5S-TgF is an inhibitor of the E.coli
Figure 2.
1H-NMRspectra(AandC)andNOEdifferencespectra(BandD)of
compounds3aand3b.(AandB)themajorisomer;(CandD)theminorisomer.
The H6 resonance was saturated in the NOE experiments.
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not the same as for T4 Endo V.
To characterize the duplexes containing TgF as inhibitors of
the Endo III reaction further,
32P-labeled, thymine glycol-
containing duplexes without ﬂuorine were treated with
Endo III in the presence of the 13 bp duplex containing
TgF. Consistent with the result of the EMSAs shown in
Figure 6, the activity of Endo III for either duplex containing
5R-o r5 S-thymine glycol was inhibited by the 5S-TgF-
containing duplex in a concentration-dependent manner, but
the 5R-TgF-containing one did not work (Figure 8). This result
supported the distinct binding capacities of the 5R-TgF and
5S-TgF duplexes for Endo III. For quantitative analysis of the
inhibition by the 5S-TgF-containing duplex, enzymatic
parameters (kcat and Km) and the inhibition constant (Ki)
were determined. Comparison of the enzymatic parameters
Figure3.HPLCanalysesofcrudeoligonucleotidesonareversedphasecolumn.(A)5R-TgF13mer,(B)5S-TgF13mer,(C)5R-TgF40merand(D)5S-TgF40mer.The
acetonitrile gradients were 6–11% and 7–13% for the 13 and 40mers, respectively.
Figure 4. Analysis of the 5R-TgF (A) and 5S-TgF (B) 13mers by MALDI-TOF mass spectrometry. The calculated molecular weight is 3977.69.
Nucleic Acids Research, 2006, Vol. 34, No. 5 1547Figure5.FormationofthecovalentintermediatesintheEndoIIIreaction.The13bpduplexes(10nM)wereincubatedwithE.coliEndoIIIinthepresenceorabsence
of NaBH4, and the reaction mixtures were analyzed by 10% SDS–PAGE.
Figure 6. Binding of endonuclease III to the duplexes containing TgF. The 13 bp duplexes (10 nM) were incubated with E.coli Endo III at 0 C for 30 min, and the
mixtures were analyzed by 6% non-denaturing PAGE.
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duplex had a higher afﬁnity for Endo III than the 5R coun-
terpart (Table 1). The Lineweaver–Burk plot obtained in the
presence of the 5S-TgF competitor exhibited a feature char-
acteristic of the competitive reaction. The kcat values without
and with the 5S-TgF-containing duplex as a competitor were
comparable, whereas the Km value with the competitor was
notably higher than that without it. The inhibition constant
(Ki ¼ 276 nM in Table 1) was signiﬁcantly higher than the
Km values obtained for the duplexes containing 5S- and
5R-thymine glycols (31 and 132 nM, respectively), and this
result shows that the 5S-TgF-containing duplex is a relatively
weak inhibitor of Endo III.
DISCUSSION
In this study, we intended to use a ﬂuorinated sugar moiety as a
mechanism-based inhibitor of Endo III. This enzyme forms a
covalent Schiff base-type intermediate with the substrate
DNA,in the same way asT4 Endo V(Scheme 1).We expected
thataﬂuorineatomattachedatthe 20 positionwouldinhibitthe
Endo III reaction by stabilizing the cyclic hemiacetal form of
the enzyme-linked sugar moiety, and such a substrate analog
would be useful for elucidation of the recognition mechanism
of this enzyme by X-ray crystallography.
In the synthesis of the building block of TgF, the OsO4
oxidation of the protected 20-ﬂuorothymidine resulted in
formation of the (5R,6S)- and (5S,6R)-thymine glycols (2a
and 2b, respectively) in the ratio of 3:1. This ratio was 6:1
when thymidine with the same protecting groups was oxidized
under the same conditions (18), and a large-scale preparation
was required to obtain the (5S,6R) isomer in a yield sufﬁcient
for its incorporation into oligonucleotides (19). This change in
stereoselectivity canbeattributed totheC30-endosugarpucker
induced by the ﬂuorine substitution (21–24), and the building
blocks of both isomers were obtained at the same time in the
present study. Since several groups have recently reported that
E.coli Endo III and its mammalian counterpart distinguished
the 5R- and 5S-thymine glycols in DNA (27–29), the higher
yield of the (5S,6R) isomer is favorable for studies comparing
the stereoisomers of this damaged base. Using the phosphor-
amidite building blocks (5a and 5b), oligonucleotides contain-
ing TgF were synthesized, incorporating the thymine glycol
isomers separately, in the same way as those without the sugar
modiﬁcation (19). We conﬁrmed that triethylamine trihydro-
ﬂuoride prevented the side reaction in the deprotection of
thymine glycol-containing oligonucleotides.
The Endo III reaction was analyzed using the 13mers syn-
thesized in the present study. We were mainly interested in
whether the duplex containing TgF could form a stable cova-
lent intermediate with Endo III that was similar to that
obtained in our previous study on T4 Endo V (Figure 1).
As shown in Figure 5, such an intermediate was not formed
with E.coli Endo III. In this experiment, the covalent complex
trapped with sodium borohydride was obtained when the
thymine glycol-containing duplexes without ﬂuorine were
used, and there was a difference between 5R- and 5S-thymine
glycol. The band was detected at a lower enzyme concentra-
tion in the case of the 5S-thymine glycol-containing substrate.
This difference can be attributed to the higher afﬁnity of E.coli
Endo III for the 5S isomer, which was revealed in our previous
study (29). To determine why the covalent intermediate was
not formed with the ﬂuorine-containing substrate analogs,
enzyme binding was analyzed by EMSAs. A complex was
detected for the duplex containing 5S-TgF, but not for the
5R isomer (Figure 6). The enzyme binding to the 5S-TgF-
containing duplex was conﬁrmed by the competition experi-
ment (Figure 8). Although E.coli Endo III has a higher afﬁnity
Figure 7. Analysis of the Endo III reaction. The 13 bp duplexes (10 nM) were
incubatedwithE.coliEndoIII(10nM)at25 C,andthereactionmixtureswere
analyzed by 16% denaturing PAGE.
Figure 8. Competition of the 13 bp substrate duplexes and the TgF-containing
duplexes in the Endo III reaction. The
32P-labeled substrates without fluorine
wereincubatedwithEndoIIIinthepresenceofthecompetitorscontainingTgF.
The amounts of the nicked products (standardized to those without the
competitors) were plotted against the concentrations of the competitor. Open
circles,
32P-5R-Tg+5R-TgF;filledcircles,
32P-5R-Tg+5S-TgF;opentriangles,
32P-5S-Tg + 5R-TgF; filled triangles,
32P-5S-Tg 5S-TgF.
Table 1. Enzymatic parameters obtained for the 13 bp duplexes containing
5R- and 5S-thymine glycols and the inhibition constant of the duplex
containing 5S-TgF
Substrate Competitor kcat (min
 1) Km (nM) kcat/Km (min
 1 nM
 1) Ki (nM)
5R-Tg None 0.36 132 0.0027
5S-Tg None 0.45 31 0.015
5S-Tg 5S-TgF 0.48 40 276
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or-none results shown in Figures 6 and 8 suggest that the
sugar conformation affects the substrate recognition because
the ﬂuorine atom at the 20 position alters the sugar pucker (21–
24). Finally, the DNA glycosylase/AP lyase reaction of Endo
III was analyzed, as shown in Figure 7. Although the enzyme
bound to the duplex containing 5S-TgF, incision of this sub-
strate analog was not detected. These results indicate that the
inhibition of the Endo III reaction by 5S-TgF was caused by
the effect of the ﬂuorine atom that is different from the mech-
anism discussed in our previous study on T4 Endo V (16). The
electron-withdrawing ﬂuorine atom at the 20 position affects
the reaction of the base excision repair enzyme in two ways. It
stabilizes the glycosidic bond of the damaged base and
changes the equilibrium between the cyclic hemiacetal and
linear aldehyde forms of the deoxyribose at the AP site
towards the former that prevents the b-elimination reaction.
If the glycosidic bond is cleaved, backbone breakage occurs
during electrophoresis (30), and the oligonucleotide contain-
ing an AP site migrates slightly faster than the intact one in the
analysis by denaturing PAGE (31). In our results, both the
substrateanalogcontaining5S-TgFaftertheEndoIIItreatment
and the untreated one migrated identically on the gel, and no
shorter fragment was detected (Figure 7, the 5S-TgF lanes).
These results indicate that the ﬂuorine atom at the 20 position
of thymidine glycol inhibits the DNA glycosylase activity, not
the AP lyase step, in the Endo III reaction, by stabilizing the
glycosidic bond.
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